Professor Freimut Schliess is a biochemist with longstanding contributions in the fields of experimental hepatology and diabetology. Major scientific achievements include the discovery of hepatic insulin resistance mechanisms and of key cerebral pathways in Hepatic Encephalopathy. Today he heads the Scientific Affairs department at Profil Institute of Metabolic Research GmbH in Neuss, Germany, which is a globally operating full service CRO uniquely positioned by its focus on performing clinical trials evaluating drugs and devices for people living with obesity, diabetes and cardiometabolic disorders (www.profil.com
). At Düsseldorf Heinrich-Heine University Freimut Schliess teaches “Molecular Medicine” at the Integrated Research School of the Collaborative Research Center 974 “Communication and Systems Relevance of Liver Damage and Regeneration“. Freimut Schliess has awarded the Heinz Kalk prize for scientific achievements in hepatobiliary transport physiology and metabolism.